| Product Code: ETC6057853 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Algeria Parkinsons Disease Market Overview |
3.1 Algeria Country Macro Economic Indicators |
3.2 Algeria Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Algeria Parkinsons Disease Market - Industry Life Cycle |
3.4 Algeria Parkinsons Disease Market - Porter's Five Forces |
3.5 Algeria Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Algeria Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Algeria Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Algeria Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Algeria Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Algeria Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of Parkinson's disease in Algeria |
4.2.2 Growing elderly population in Algeria |
4.2.3 Rising healthcare expenditure and improved access to healthcare services in the country |
4.3 Market Restraints |
4.3.1 Limited availability and affordability of Parkinson's disease medications and treatments in Algeria |
4.3.2 Lack of specialized healthcare facilities and trained healthcare professionals for Parkinson's disease management in the country |
5 Algeria Parkinsons Disease Market Trends |
6 Algeria Parkinsons Disease Market, By Types |
6.1 Algeria Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Algeria Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Algeria Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Algeria Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Algeria Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Algeria Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Algeria Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Algeria Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Algeria Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Algeria Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Algeria Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Algeria Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Algeria Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Algeria Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Algeria Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Algeria Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Algeria Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Algeria Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Algeria Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Algeria Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Algeria Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Algeria Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Algeria Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Algeria Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Algeria Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Algeria Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Algeria Parkinsons Disease Market Export to Major Countries |
7.2 Algeria Parkinsons Disease Market Imports from Major Countries |
8 Algeria Parkinsons Disease Market Key Performance Indicators |
8.1 Number of neurologists specializing in movement disorders in Algeria |
8.2 Percentage of Parkinson's disease patients receiving timely and appropriate treatment |
8.3 Investment in research and development of new Parkinson's disease therapies in Algeria |
9 Algeria Parkinsons Disease Market - Opportunity Assessment |
9.1 Algeria Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Algeria Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Algeria Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Algeria Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Algeria Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Algeria Parkinsons Disease Market - Competitive Landscape |
10.1 Algeria Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Algeria Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here